PROFFERED PAPERS Monday, March 9   —  1:00 PM   —  CC 306 Click on the blue numbers in parentheses to display abstracts. Click the button next to any title to add to Itinerary Planner... Section G - PAN-GENOMICS and PAN-PROTEOMICS Chaired by: Carol L. Rosenberg and George Mutter Time Title and Authors Itinerary Planner 1:00 RUNX1T1: A Novel Putative Progression Marker in Pancreatic Endocrine Neoplasms: An Immunohistochemical Analysis (1708) LM Turner, E Henderson, J Helm, M Ghayouri, NA Nasir, BA Centeno, SV Nicosia, L Kvols, A Nasir - University of South Florida, Tampa, FL; Moffitt Cancer Center and Research Institute, Tampa, FL Add 1:15 Quantitative Assessment of Change in Protein Phosphorylation as a Function of Ischemic Time before Formalin Fixation (1667) Y Bai, A Gopinath, S Siddiqui, H Cheng, E Pectasides, RL Camp, DL Rimm - Yale Universtiy School of Medicine, New Haven, CT Add 1:30 Gene Expression Alterations in Premalignant and Preinvasive Breast Disease (1680) LA Emery, A de las Morenas, A Tripathi, P Sebastiani, CL Rosenberg - Boston University Medical Center, Boston, MA Add 1:45 Does Androgen Receptor Have a Role in a Subgroup of ER Negative Breast Cancer? (1679) ME Edgerton, S Sanga, E Downs-Kelley, V Cristini - UT MD Anderson Cancer Center, Houston, TX; University of Texas, Austin, TX; UT Houston Health Science Center, Houston, TX Add 2:00 Virtual-Karyotyping with SNP Arrays Is a Useful Approach for the Diagnosis of Morphologically Difficult Renal Cell Neoplasms (1690) HJ Kim, SS Shen, LD Truong, JY Ro, AG Ayala, K Alvarez, Z Gatalica, J Bridge, FA Monzon - The Methodist Hospital Research Institute, Houston, TX; Inje University College of Medicine, Sanggye Paik Hospital, Seoul, Korea; Creighton University and University of Nebraska, Omaha, NE Add 2:15 Distinct Genomic Aberrations Associated with TMPRSS2-ERG Fusion Prostate Cancer (1677) F Demichelis, SR Setlur, R Beroukhim, S Perner, JO Korbel, C Lafargue, D Pflueger, C Pina, MD Hofer, A Sboner, MA Svensson, DS Rickman, M Meyerson, C Lee, MB Gerstein, R Kuefer, MA Rubin - Weill Cornell Medical College, New York, NY; Brigham and Women's Hospital, Boston, MA; Broad Institute of M.I.T. and Harvard, Cambridge, MA; Dana Farber Cancer Institute, Cambridge, MA; Yale University, New Haven, CT; University Hospital Ulm, Ulm, Germany Add 2:30 Multiplex Quantum Dot ISH in Tissue Microarrays Identifies HOXA9 and DNMT3A as Unfavourable Markers in Acute Myeloid Leukaemia (1707) E Tholouli, S McDermott, JA Hoyland, C Glennie, R Swindell, JA Liu Yin, RJ Byers - Manchester Royal Infirmary, Manchester, United Kingdom; University of Manchester, Manchester, United Kingdom; Christie Hospital, Manchester, United Kingdom Add 2:45 MicroRNA-based Assay for Diagnosing Tumor Tissue Origin (1701) S Rosenwald, I Barshak, D Lebanony, H Gibory, L Cohen, Y Goren, I Leizerman, D Nonaka, A Tobar, Z Bentwich, R Aharonov, N Rosenfeld, D Cohen - Rosetta Genomics, Rehovot; Sheba Medical Center, Tel-Hashomer; Tel-Aviv University, Tel-Aviv, Israel Add 3:00 RECESS, EXHIBITS, POSTER SESSION II   4:30 NATHAN KAUFMAN TIMELY TOPICS LECTURE Todd R. Golub, M.D. Molecular Classification of Tumors Hynes Convention Center Auditorium Add